Radicava ORS Disease Interactions
There are 2 disease interactions with Radicava ORS (edaravone).
Edaravone (applies to Radicava ORS) asthma
Moderate Potential Hazard, Moderate plausibility.
Edaravone contains sodium bisulfite, a sulfite that may cause allergic reactions, including life-threatening or less severe asthmatic episodes in susceptible people. Sulfite sensitivity occurs more frequently in asthmatic than non-asthmatic people. Patients should be advised to seek immediate medical care if they experience signs and symptoms of asthma.
Edaravone (applies to Radicava ORS) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Edaravone has not been studied in patients with severe renal impairment. No dosage modifications are required in patients with mild or moderate renal impairment.
Switch to professional interaction data
Radicava ORS drug interactions
There are 19 drug interactions with Radicava ORS (edaravone).
Report options
More about Radicava ORS (edaravone)
- Radicava ORS consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Radicava
Radicava (edaravone) is used to treat amyotrophic lateral sclerosis (ALS). Includes Radicava side ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Qalsody
Qalsody (tofersen) is a prescription medicine used to treat amyotrophic lateral sclerosis (ALS) in ...
Relyvrio
Relyvrio (sodium phenylbutyrate and taurursodiol) was a neuroprotective therapy for the treatment ...
Sodium phenylbutyrate/taurursodiol
Sodium phenylbutyrate/taurursodiol systemic is used for amyotrophic lateral sclerosis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
